Receptor activator of nuclear factor-kappaB ligand (RANKL) and its receptor RANK play critical roles in breast cancer development, both during initial tumorigenesis and in the formation of secondary tumors in the bone [49]. Here, TNFRSF11A is linked to breast carcinoma.